Not applicableStudy completedNCT02111889What this trial is testingTumor Kinase Inhibitor Concentrations Measured by PETWho this might be right forDisseminated Malignant Neoplasm Amsterdam UMC, location VUmc 8
Testing effectiveness (Phase 2)WithdrawnNCT04105062What this trial is testingLS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric SurgeryWho this might be right forPancreatic CancerLiver CancerGastric Cancer+2 more Washington University School of Medicine
Not applicableActive Not RecruitingNCT05708703What this trial is testingAssessing the Time Demands of CancerWho this might be right forMetastatic Breast CancerOvarian Cancer Masonic Cancer Center, University of Minnesota 78
Large-scale testing (Phase 3)Looking for participantsNCT06927986What this trial is testingPhase III Trial of SYS6010 Versus Platinum-based Chemotherapy for EGFR-mutated NSCLC（SYNSTAR01）Who this might be right forEGFR-mutated Locally Advanced or Metastatic NSCLC CSPC Megalith Biopharmaceutical Co.,Ltd. 380
Large-scale testing (Phase 3)WithdrawnNCT06585969What this trial is testingA Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast CancerWho this might be right forMetastatic Breast CancerER-positive Breast CancerLuminal B+2 more Danish Breast Cancer Cooperative Group
Not applicableUnknownNCT04145973What this trial is testingEvaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After SurgeryWho this might be right forBreast Cancer Peking Union Medical College Hospital 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07005583What this trial is testingClinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast CancerWho this might be right forTriple-Negative Breast Cancer (TNBC) Tianjin Medical University Cancer Institute and Hospital 46
Early research (Phase 1)Looking for participantsNCT05176483What this trial is testingStudy of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid TumorsWho this might be right forRenal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more Exelixis 1,314
Very early researchUnknownNCT05459441What this trial is testingEfficacy and Safety Evaluation of Percutaneous Ommaya Capsule Injection of Autologous Bi-dimensional Specific T Cells in the Treatment of Glioma and in Combination With Pemetrexed in the Treatment of Brain/Meningeal MetastasesWho this might be right forGliomaBrain Metastases Shanghai Pudong Hospital 30
Early research (Phase 1)UnknownNCT03282617What this trial is testingDendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Cancer National University Hospital, Singapore 55
Testing effectiveness (Phase 2)UnknownNCT01283789What this trial is testingLapatinib and RAD-001 for HER2 Positive Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer University of Kansas Medical Center 23
Early research (Phase 1)WithdrawnNCT02105350What this trial is testingMEK162 With Gemcitabine and Oxaliplatin in Biliary CancerWho this might be right forBiliary Tract CarcinomaGallbladder Carcinoma University Health Network, Toronto
Early research (Phase 1)Ended earlyNCT02595918What this trial is testingNivolumab in Treating Patients With High-Risk Kidney Cancer Before SurgeryWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Renal Cell CarcinomaStage I Renal Cell Cancer AJCC v6 and v7+3 more National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Ended earlyNCT01689974What this trial is testingPhase II Randomized Trial of Ipilimumab Versus Ipilimumab and Radiotherapy in Metastatic MelanomaWho this might be right forMetastatic Melanoma NYU Langone Health 10
Not applicableStudy completedNCT06856590What this trial is testingZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin ReactionWho this might be right forHand-Foot Skin Reaction (HFSR) Gazi University 150
Testing effectiveness (Phase 2)Ended earlyNCT00006113What this trial is testingVaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV MelanomaWho this might be right forMelanoma (Skin) University of Southern California 25
Testing effectiveness (Phase 2)UnknownNCT01266213What this trial is testingFulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal WomenWho this might be right forMetastatic Breast CancerEstrogen Receptor Positive TumorBreast Cancer Nos Premenopausal Samsung Medical Center 147
Testing effectiveness (Phase 2)UnknownNCT05512520What this trial is testingConcurrent Chemoradiotherapy for Stage IVB Esophageal Squamous Cell Carcinoma（EC-CRT-003）Who this might be right forMetastatic Esophageal Squamous Cell Carcinoma Sun Yat-sen University 126
Early research (Phase 1)UnknownNCT01266720What this trial is testingHLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)Who this might be right forPancreatic Cancer Fukushima Medical University 6
Not applicableLooking for participantsNCT04854213What this trial is testingPRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)Who this might be right forColorectal Cancer Metastatic National Cancer Institute, Naples 25